
Reset all filters
01 2Zynlonta
Main Therapeutic Indication : Hematology
Currency : USD
2023 Revenue in Millions : 3
2022 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Hematology
Currency : USD
2024 Revenue in Millions : 10
2023 Revenue in Millions : 3
Growth (%) : 225